Stay updated with breaking news from 58958410. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Meridian Bioscience (NASDAQ:VIVO – Get Rating) issued an update on its FY 2022 earnings guidance on Monday morning. The company provided earnings per share guidance of $1.30-$1.40 for the period, compared to the consensus earnings per share estimate of $1.37. The company issued revenue guidance of $330.00 million-$345.00 million, compared to the consensus revenue estimate […]
Meridian Bioscience (NASDAQ:VIVO – Get Rating) updated its FY 2022 earnings guidance on Monday. The company provided EPS guidance of $1.30-$1.40 for the period, compared to the consensus EPS estimate of $1.37. The company issued revenue guidance of $330.00 million-$345.00 million, compared to the consensus revenue estimate of $337.62 million. Several equities analysts have commented […]
Meridian Bioscience (NASDAQ:VIVO – Get Rating) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research report issued on Tuesday, Zacks.com reports. According to Zacks, “Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, […]
HC Wainwright reaffirmed their buy rating on shares of Meridian Bioscience (NASDAQ:VIVO – Get Rating) in a report released on Friday morning, TipRanks reports. The brokerage currently has a $30.00 target price on the stock. Several other research analysts also recently issued reports on the company. StockNews.com initiated coverage on Meridian Bioscience in a report […]
Wall Street analysts expect Meridian Bioscience, Inc. (NASDAQ:VIVO – Get Rating) to report $83.30 million in sales for the current quarter, according to Zacks. Two analysts have issued estimates for Meridian Bioscience’s earnings. The highest sales estimate is $88.10 million and the lowest is $78.50 million. Meridian Bioscience reported sales of $85.26 million in the […]